cefotaxime
Generic: cefotaxime injection
Labeler: sterimax inc.Drug Facts
Product Profile
Brand Name
cefotaxime
Generic Name
cefotaxime injection
Labeler
sterimax inc.
Dosage Form
POWDER, FOR SOLUTION
Routes
Active Ingredients
cefotaxime sodium 2 g/1
Manufacturer
Identifiers & Regulatory
Product NDC
21586-012
Product ID
21586-012_425c90b3-5006-427e-95f6-93ee7918fb8b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
Listing Expiration
2026-12-31
Marketing Start
2019-08-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
21586012
Hyphenated Format
21586-012
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cefotaxime (source: ndc)
Generic Name
cefotaxime injection (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 g/1
Packaging
- 10 VIAL in 1 PACKAGE (21586-012-02) / 1 POWDER, FOR SOLUTION in 1 VIAL (21586-012-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "425c90b3-5006-427e-95f6-93ee7918fb8b", "openfda": {"unii": ["258J72S7TZ"], "rxcui": ["1656313", "1656318"], "spl_set_id": ["8efe3bd0-c43a-2bd6-e053-2a95a90a92fa"], "manufacturer_name": ["SteriMax Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 PACKAGE (21586-012-02) / 1 POWDER, FOR SOLUTION in 1 VIAL (21586-012-01)", "package_ndc": "21586-012-02", "marketing_start_date": "20190801"}], "brand_name": "Cefotaxime", "product_id": "21586-012_425c90b3-5006-427e-95f6-93ee7918fb8b", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Cephalosporin Antibacterial [EPC]", "Cephalosporins [CS]"], "product_ndc": "21586-012", "generic_name": "cefotaxime injection", "labeler_name": "SteriMax Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cefotaxime", "active_ingredients": [{"name": "CEFOTAXIME SODIUM", "strength": "2 g/1"}], "marketing_category": "UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE", "marketing_start_date": "20190801", "listing_expiration_date": "20261231"}